Skip to main navigation
About Alexion
Our Leadership
Our Partnerships
Our Ethical Standards
Our History
Main Menu
Patient Focus
Advocacy
Patient Stories
Main Menu
Therapies
Soliris
®
Products
Soliris®
PNH
aHUS
Main Menu
Strensiq
®
Kanuma
®
Main Menu
Research & Development
Our Pipeline
Development Programs
Investigator-Sponsored Research
Preclinical Partnerships
Main Menu
Responsibility
Global Access to Medicines Policy
Main Menu
Careers
Job Opportunities
Why Choose Alexion
Careers
Why Choose Alexion
Culture
Compensation & Benefits
Careers
Why Choose Alexion
Compensation & Benefits
Work/Life Balance
Health & Wellness
Financial Security
Recognition & Rewards
Personal Growth & Development
Main Menu
Professional Development
Main Menu
Main Menu
Select a Country
North America
Select a Country
North America
Canada
USA
Main Menu
Latin America
Select a Country
Select a Country
North America
Latin America
Argentina
Brazil
Colombia
Mexico
Main Menu
Europe, the Middle East & Africa
Select a Country
Select a Country
North America
Select a Country
Select a Country
North America
Latin America
Europe, the Middle East & Africa
Alexion Europe
Belgium
Denmark
France
Germany
Ireland
Italy
Netherlands
Norway
Russia
Spain
Sweden
Switzerland
Turkey
UAE
UK
Main Menu
Asia Pacific
Select a Country
Select a Country
North America
Select a Country
Select a Country
North America
Latin America
Select a Country
Select a Country
North America
Select a Country
Select a Country
North America
Latin America
Europe, the Middle East & Africa
Asia Pacific
Australia
China
India
Japan
Main Menu
Main Menu
Investors
Investor mobile menu
Events & Presentations
Annual Reports
SEC Filings
Stock Information
Acquisitions
Historical Lookup
Investment Calculator
IRS Disclosures
Corporate Governance
Committee Composition
Report a Concern
News
Main Menu
Select a Country
Investors
News
Contact
Search for:
North America
Canada
United States
Latin America
Argentina
Brazil
Colombia
Mexico
Europe, the Middle East & Africa
Alexion Europe
Belgium
Denmark
France
Germany
Ireland
Italy
Netherlands
Norway
Russia
Spain
Sweden
Switzerland
Turkey
UAE
United Kingdom
Asia Pacific
Australia
China
India
Japan
About Alexion
Our Leadership
Our Partnerships
Our Ethical Standards
Our History
Patient Focus
Advocacy
Patient Stories
Therapies
Soliris
®
PNH
aHUS
Strensiq
®
Kanuma
®
Research & Development
Our Pipeline
Development Programs
Investigator-Sponsored Research
Preclinical Partnerships
Responsibility
Global Access to Medicines Policy
Careers
Job Opportunities
Why Choose Alexion
Culture
Compensation & Benefits
Work/Life Balance
Health & Wellness
Financial Security
Recognition & Rewards
Personal Growth & Development
Professional Development
Select a Country
North America
Canada
USA
Latin America
Argentina
Brazil
Colombia
Mexico
Europe, the Middle East & Africa
Alexion Europe
Belgium
Denmark
France
Germany
Ireland
Italy
Netherlands
Norway
Russia
Spain
Sweden
Switzerland
Turkey
UAE
UK
Asia Pacific
Australia
China
India
Japan
Investors
Investor Relations
Events & Presentations
Annual Reports
SEC Filings
Stock Information
Corporate Governance
News
Contact
Investor Relations
Events & Presentations
Annual Reports
SEC Filings
Stock Information
Corporate Governance
Skip to content
Breadcrumb
Home
»
Investor Relations
»
Unsubscribe from all Alexion Pharmaceuticals, Inc. email alerts
Email Address
Shareholder Tools
Shareholder Tools
Email Alerts
RSS
Print
Share
Inquiries
Facebook
Google
LinkedIn
Twitter
RSS
Close